LLY

748.51

-1.17%↓

JNJ

152

+0.47%↑

UNH

302

+3.69%↑

ABBV

183.75

-0.11%↓

NVO

66.05

+2.66%↑

LLY

748.51

-1.17%↓

JNJ

152

+0.47%↑

UNH

302

+3.69%↑

ABBV

183.75

-0.11%↓

NVO

66.05

+2.66%↑

LLY

748.51

-1.17%↓

JNJ

152

+0.47%↑

UNH

302

+3.69%↑

ABBV

183.75

-0.11%↓

NVO

66.05

+2.66%↑

LLY

748.51

-1.17%↓

JNJ

152

+0.47%↑

UNH

302

+3.69%↑

ABBV

183.75

-0.11%↓

NVO

66.05

+2.66%↑

LLY

748.51

-1.17%↓

JNJ

152

+0.47%↑

UNH

302

+3.69%↑

ABBV

183.75

-0.11%↓

NVO

66.05

+2.66%↑

Search

DaVita Inc

Gesloten

SectorGezondheidszorg

141.97 -2.21

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

144.37

Max

145.18

Belangrijke statistieken

By Trading Economics

Inkomsten

135M

349M

Verkoop

35M

3.3B

K/W

Sectorgemiddelde

13.473

56.602

EPS

2

Winstmarge

10.6

Werknemers

76,000

EBITDA

11M

729M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+9.81% upside

Dividenden

By Dow Jones

Volgende Winsten

5 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.4B

11B

Vorige openingsprijs

144.18

Vorige sluitingsprijs

141.97

Nieuwssentiment

By Acuity

50%

50%

160 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

DaVita Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 feb 2025, 19:50 UTC

Belangrijke Marktbewegers

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 mrt 2025, 08:19 UTC

Marktinformatie

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15 jul 2024, 08:17 UTC

Marktinformatie

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Peer Vergelijking

Prijswijziging

DaVita Inc Prognose

Koersdoel

By TipRanks

9.81% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 159.67 USD  9.81%

Hoogste 169 USD

Laagste 145 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor DaVita Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

4 ratings

0

Buy

3

Hold

1

Sell

Technische score

By Trading Central

142.36 / 144.275Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

160 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.